EcoDrugPlus

Ttk Protein Kinase

Ensembl ID : ENSCMIG00000012216
Gene Symbol: TTK
4 Cross references
205 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSCMIG00000009815
Gene Symbol: UGCG
4 Cross references
212 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSCMIG00000014969
Gene Symbol: WEE1
3 Cross references
227 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSCMIG00000016349
Gene Symbol: YES1
4 Cross references
276 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSCMIG00000005262
Gene Symbol: ACHE
1 Cross references
234 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSCMIG00000003664
Gene Symbol: ACVR2B
4 Cross references
259 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSCMIG00000000245
Gene Symbol: ADORA1
4 Cross references
280 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSCMIG00000013019
Gene Symbol: ADORA2A
3 Cross references
264 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSCMIG00000013039
Gene Symbol: ADA
3 Cross references
216 Possible Orthologues:

Adenosine Deaminase-Like

Ensembl ID : ENSCMIG00000001580
Gene Symbol: LOC103180762
3 Cross references
218 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSCMIG00000003942
Gene Symbol: ADRA1A
4 Cross references
203 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSCMIG00000007704
Gene Symbol: ADRA1B
4 Cross references
265 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).